Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
<p>Abstract</p> <p>Background</p> <p>Uncovering the molecular mechanism underlying expansion of hematopoietic stem and progenitor cells is critical to extend current therapeutic applications and to understand how its deregulation relates to leukemia. The characterizatio...
Main Authors: | Vêncio Ricardo Z, Marti Luciana C, Carvalho Ana Carolina SR, Okamoto Oswaldo, Moreira-Filho Carlos A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-06-01
|
Series: | Cancer Cell International |
Online Access: | http://www.cancerci.com/content/7/1/11 |
Similar Items
-
Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
by: Fritzenwanger M, et al.
Published: (2009-03-01) -
CD34/CD133 enriched bone marrow progenitor cells promote neovascularization of tissue engineered constructs in vivo
by: Marietta Herrmann, et al.
Published: (2014-11-01) -
Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients
by: Frank Joseph, et al.
Published: (2011-08-01) -
Characterization of Megakaryocyte Progenitor Cells Differentiated from Umbilical Cord Blood CD133+ and CD133– Cells
by: Alireza Goodarzi, et al.
Published: (2007-01-01) -
Mobilization of CD133+ progenitor cells in patients with acute cerebral infarction.
by: Dominik Sepp, et al.
Published: (2014-01-01)